webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

mPEG6-amine

  CAS No.: 184357-46-8   Cat No.: BADC-01011   Purity: ≥95% 4.5  

mPEG6-amine is a mid-length PEG linker offering terminal amine reactivity, commonly used in antibody-drug conjugation. Its PEG6 spacer enhances flexibility, solubility, and stability, contributing to improved pharmacokinetics of ADC therapeutics.

mPEG6-amine

Structure of 184357-46-8

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C13H29NO6
Molecular Weight
295.37
Shipping
Room temperature
Shipping
Store at 2-8°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
m-PEG6-amine; 2,5,8,11,14,17-Hexaoxanonadecan-19-amine; mPEG6-NH2; 1-amino-3,6,9,12,15,18-hexaoxanonadecane; 3,6,9,12,15,18-Hexaoxanonadecan-1-amine; Methyl-PEG6-amine; H2N-(CH2CH2O)6-Me
IUPAC Name
2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanamine
Canonical SMILES
COCCOCCOCCOCCOCCOCCN
InChI
InChI=1S/C13H29NO6/c1-15-4-5-17-8-9-19-12-13-20-11-10-18-7-6-16-3-2-14/h2-14H2,1H3
InChIKey
JDTWBXXBTWYNAT-UHFFFAOYSA-N
Density
1.036±0.06 g/cm3 (Predicted)
Solubility
Soluble in DCM, DMF, DMSO, Water
PSA
81.40000
Appearance
Pale Yellow or Colorless Oily Matter
Shipping
Room temperature
Storage
Store at 2-8°C
Boiling Point
368.5±37.0 °C at 760 mmHg
Form
Solid

mPEG6-amine, a polyethylene glycol molecule featuring an amine group, showcases exceptional versatility in bioconjugation and drug delivery applications.

Drug Delivery Systems: The widespread integration of mPEG6-amine in formulating drug delivery systems underscores its pivotal role in augmenting the solubility and stability of therapeutic agents. By coupling drugs with mPEG6-amine, pharmaceutical entities can enhance drug pharmacokinetics and mitigate immunogenic responses.

Protein Modification: Within the domain of protein engineering, mPEG6-amine emerges as a coveted reagent for PEGylation, a transformative process entailing the attachment of polyethylene glycol chains to proteins. This modification confers heightened protein stability, reduced immunogenicity, and prolonged protein half-life within the physiological milieu. The amine moiety of mPEG6-amine facilitates precise and efficient protein surface conjugation, establishing it as an indispensable tool in the realm of therapeutic protein advancement.

Diagnostic Imaging: Harnessing mPEG6-amine for enhancing imaging agents serves as a testament to its profound impact on biocompatibility and circulation duration. Through the linkage of mPEG6-amine to imaging moieties, researchers can amplify the contrast and specificity of diagnostic instruments in medical imaging modalities like MRI and PET scans. This application assumes a pivotal role in ensuring precise disease diagnosis by yielding vivid and accurate imaging results.

Surface Modification: In the dynamic arena of biomaterials science, mPEG6-amine finds extensive utilization in surface modification initiatives pertaining to medical devices and implants. By coating surfaces with mPEG6-amine, researchers can effectively mitigate biofouling occurrences and cultivate enhanced biocompatibility. This strategic surface alteration hampers protein adsorption and cellular attachment, thereby reducing the risk of infection and inflammation.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Me-Tet-PEG4-COOH
Send Inquiry
Verification code
Inquiry Basket